Yamin Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yamin Liang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Dangheng Wei
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China
2 shared publications Lu Li
Key Laboratory for Arteriosclerology of Hunan Province, Institute of Cardiovascular Disease, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, University of South China, Hengyang, China
2 shared publicationsYanmei Chen
Key Laboratory for Arteriosclerology of Hunan Province, Institute of Cardiovascular Disease, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, University of South China, Hengyang, China
2 shared publications- Jinyan Xiao
YueYang Maternal-Child Medicine Health Hospital Hunan Province Innovative Training Base for Medical Postgraduates, University of China South China and Yueyang Women and Children's Medical Center, Yueyang, Hunan, China
1 shared publication - Peng Wu
Hengyang Maternal and Child Health Hospital, Hengyang 421001, Hunan Province, China
1 shared publication Shulei Zhang
Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Institute of Cardiovascular Disease, Hengyang Medical College, University of South China, Hengyang, Hunan, China
1 shared publication
Latest Publications
- 1 March 2022
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (3) , 285-291
Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression
Succinate is an important intermediate product of mitochondrial energy metabolism. Recent studies revealed that beyond its known traditional metabolic functions, succinate plays important roles in signal transduction, immunity, inflammation, and posttranslational modification. Recent studies showed that patients and mouse models with cardiovascular disease have high levels of serum succinate and succinate accumulation. Atherosclerosis (As) is the pathological basis of cardiovascular and peripheral vascular diseases, such as coronary heart disease, cerebral infarction, and peripheral vascular disease, and is a major factor affecting human health. This article reviews the progression of succinate in As diseases and its underlying mechanisms.
- 1 March 2022
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (3) , 285-291
Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression
Succinate is an important intermediate product of mitochondrial energy metabolism. Recent studies revealed that beyond its known traditional metabolic functions, succinate plays important roles in signal transduction, immunity, inflammation, and posttranslational modification. Recent studies showed that patients and mouse models with cardiovascular disease have high levels of serum succinate and succinate accumulation. Atherosclerosis (As) is the pathological basis of cardiovascular and peripheral vascular diseases, such as coronary heart disease, cerebral infarction, and peripheral vascular disease, and is a major factor affecting human health. This article reviews the progression of succinate in As diseases and its underlying mechanisms.
- 16 December 2021
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 40 (12) , 1495-1502
Research Progress on the Role of Intermediate Filament Vimentin in Atherosclerosis
The cytoskeleton is a biopolymer network composed of intermediate filaments, actin, and microtubules, which is the main mechanical structure of cells. Vimentin is an intermediate filament protein that regulates the mechanical and contractile properties of cells, thereby reflecting their mechanical properties. In recent years, the “nonmechanical function” of vimentin inside and outside of cells has attracted extensive attention. The content of vimentin in atherosclerotic plaques is increased, and the serum secretion of vimentin in patients with coronary heart disease is remarkably increased. In this review, the mechanistic and nonmechanistic roles of vimentin in atherosclerosis progression were summarized on the basis of current studies.
- 16 December 2021
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 40 (12) , 1495-1502
Research Progress on the Role of Intermediate Filament Vimentin in Atherosclerosis
The cytoskeleton is a biopolymer network composed of intermediate filaments, actin, and microtubules, which is the main mechanical structure of cells. Vimentin is an intermediate filament protein that regulates the mechanical and contractile properties of cells, thereby reflecting their mechanical properties. In recent years, the “nonmechanical function” of vimentin inside and outside of cells has attracted extensive attention. The content of vimentin in atherosclerotic plaques is increased, and the serum secretion of vimentin in patients with coronary heart disease is remarkably increased. In this review, the mechanistic and nonmechanistic roles of vimentin in atherosclerosis progression were summarized on the basis of current studies.